Page 200 - Haematologica Vol. 110 - January 2025

LETTER TO THE EDITOR
3. Sugrañes TA, Flanagan M, Thomas C, Chang VY, Walsh M, Cunniff C. Age of first cancer diagnosis and survival in Bloom syndrome. Genet Med. 2022;24(7):1476-1484.
4. Laitman Y, Boker-Keinan L, Berkenstadt M, et al. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers. Cancer Genet. 2016;209(3):70-74.
5. Bogdanova N, Togo AV, Ratajska M, et al. Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. Fam Cancer. 2015;14(1):145-149.
6. de Voer RM, Hahn M-M, Mensenkamp AR, et al. Deleterious germline BLM mutations and the risk for early-onset colorectal cancer. Sci Rep. 2015;5:14060.
7. Thompson ER, Doyle MA, Ryland GL, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet. 2012;8(9):e1002894.
8. Bononi A, Goto K, Ak G, et al. Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma. Proc Natl Acad Sci U S A. 2020;117(52):33466-33473.
9. Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J
Med. 2014;371(26):2488-2498.
10. Bick AG, Weinstock JS, Nandakumar SK, et al. Inherited causes
of clonal haematopoiesis in 97,691 whole genomes. Nature.
2020;586(7831):763-768.
11. Schratz KE, Haley L, Danoff SK, et al. Cancer spectrum and
outcomes in the Mendelian short telomere syndromes. Blood.
2020;135(22):1946-1956.
12. Liu J, Tran D, Chan ICC, et al. Genetic determinants of clonal
hematopoiesis and progression to hematologic malignancies in
479,117 individuals. Blood. 2023;142(Suppl 1):811.
13. McKenna A, Hanna M, Banks E, et al. The genome analysis
toolkit: a MapReduce framework for analyzing next-generation
DNA sequencing data. Genome Res. 2010;20(9):1297-1303.
14. Coffee B, Cox HC, Bernhisel R, et al. A substantial proportion of
apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically. Hum Mutat. 2020;41(1):203-211.
15. Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9-16.
Haematologica | 110 January 2025
192